Jto 2024

3 papers

Top Research Directions

The 5 research directions with Jto 2024 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Building Empirical Null Distributions Through Permutation Testing133.3%
2Closing the Early Stage Cancer Diagnostic Gap133.3%
3Designing Machine Learning Models to Minimize False Negatives133.3%
4Machine Learning for Granular Prognostic Risk Stratification133.3%
5Transforming Continuous Biomarkers into Actionable Clinical Thresholds133.3%

Download all directions as CSV

Institutions

Institutions credited by Jto 2024 papers: a paper credits every institution named in its affiliations, once. 8 institutions share 1 credited papers.

#InstitutionPapersShare
1029nzwk08 1100.0%
202ddqp560 1100.0%
302jk5qe80 1100.0%
402mfv5g23 1100.0%
5Ilia State University 1100.0%
6King Abdullah University of Science and Technology 1100.0%
7Norwegian University of Science and Technology 1100.0%
8University of Crete 1100.0%

Download all institutions as CSV

About this data

Papers. Jto 2024 lists 3 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 3 papers (33.3%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Jto 2024”, https://lacuna.tiptreesystems.com/venue/jto/2024.

Top Authors

AuthorPapers
Jorge J. Nieva2

Papers

Title
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator’s Consortium Registry Analysis
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC
Improving Lung Cancer Screening Selection: The HUNT Lung Cancer Risk Model for Ever-Smokers Versus the NELSON and 2021 United States Preventive Services Task Force Criteria in the Cohort of Norway: A